AAK1 | AP2 associated kinase 1 | Enzymes
| | | | | Expressed in all |
AAMDC | Adipogenesis associated, Mth938 domain containing | | | | | | Expressed in all |
ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted membrane proteins Transporters
| | | | | Mixed |
ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
ABHD14A-ACY1 | ABHD14A-ACY1 readthrough (NMD candidate) | | | | | | Mixed |
ACADM | Acyl-CoA dehydrogenase, C-4 to C-12 straight chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ACADSB | Acyl-CoA dehydrogenase, short/branched chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ACADVL | Acyl-CoA dehydrogenase, very long chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ACBD5 | Acyl-CoA binding domain containing 5 | Predicted membrane proteins
| | | | | Expressed in all |
ACSL1 | Acyl-CoA synthetase long-chain family member 1 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL4 | Acyl-CoA synthetase long-chain family member 4 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ACSL5 | Acyl-CoA synthetase long-chain family member 5 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSS2 | Acyl-CoA synthetase short-chain family member 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AFAP1L2 | Actin filament associated protein 1-like 2 | | | | | | Tissue enhanced |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGL | Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
AGTRAP | Angiotensin II receptor-associated protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AKAP1 | A kinase (PRKA) anchor protein 1 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AKT3 | V-akt murine thymoma viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AKTIP | AKT interacting protein | Plasma proteins
| | | | | Expressed in all |
ALDH16A1 | Aldehyde dehydrogenase 16 family, member A1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALDH1B1 | Aldehyde dehydrogenase 1 family, member B1 | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
ALDH1L2 | Aldehyde dehydrogenase 1 family, member L2 | Enzymes
| | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes
| | | | | Tissue enhanced |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ALDH7A1 | Aldehyde dehydrogenase 7 family, member A1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ALG2 | ALG2, alpha-1,3/1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMIGO3 | Adhesion molecule with Ig-like domain 3 | Predicted membrane proteins
| | | | | Mixed |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO2 | Anoctamin 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOL6 | Apolipoprotein L, 6 | Predicted membrane proteins
| | | | | Expressed in all |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ARHGAP1 | Rho GTPase activating protein 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |